Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Directorate Change

18 Nov 2014 07:00

RNS Number : 2923X
Quindell PLC
18 November 2014
 



Quindell Plc

 

("Quindell" or the "Company" or the "Group")

 

Directorate Change

 

Quindell Plc (AIM: QPP.L), a market leading global provider of professional services and digital solutions, announces that Robert Terry, the Company's Chairman, has resigned from the Board of Directors with immediate effect.

 

The Directors believe that, in order to ensure an orderly transition, it is desirable to retain Mr Terry on a consultancy basis with particular focus on the Group's key relationships and he will be available to assist the Board, where appropriate, in executing its strategy.

 

David Currie will become non-Executive Interim Chairman of the Company with immediate effect and a process has begun to find a new Chairman.

 

Laurence Moorse, Group Finance Director, has agreed with the Company that, following the 2015 Annual General Meeting of the Company, he will step down from the Board. Mr Moorse has agreed to remain with the Company thereafter for a period of up to twelve months in order to effect an orderly handover.

 

Steve Scott, a non-executive director of Quindell, has agreed with the Company that he will step down from the Board with immediate effect.

 

The Board remains confident in the future prospects of the business.

 

David Currie, Quindell's non-Executive Interim Chairman, commented:

 

"Rob is the founder of the business and has made a huge contribution to Quindell's growth to date and the Board thanks him for that. We look forward to completing our search for a new Chairman and additional non-executive directors as soon as possible."

 

Robert Terry said:

 

"I entered into the share transactions announced on 5 November 2014, with the best of intentions for the Company and all shareholders and it would have been my intention to acquire more shares were it not for the restrictions due to the discussions leading to this announcement. I am clearly disappointed and sorry that events turned out as they did.

 

"In view of the share price performance of the last few days, it is likely that a margin call will be made in relation to the share transactions and, at the current share price, I would expect to relinquish my rights to acquire 8,850,000 shares under the EFH Sale and Repurchase Agreement, rather than satisfying the margin call as this would now no longer make economic sense. This will draw a line under this Agreement and I have no intention of making further use of this Agreement or its like again."

 

For further information:

 

Quindell Plc Tel: 01489 864200

David Currie, non-Executive Interim Chairman

Stephen Joseph, Head of Investor Relations

 

Cenkos Securities plc, Nominated Adviser and broker Tel: 020 7397 8900

Stephen Keys/Mark Connolly

 

Bell Pottinger Tel: 020 3772 2562

Victoria Geoghegan/Will Powell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABPBFTMBJBMFI
Date   Source Headline
10th Feb 20207:00 amRNSPre-close update
7th Feb 20207:00 amRNSCompletion of the sale of Healthcare Services
3rd Feb 20207:00 amRNSUpdate re the sale of Healthcare services business
23rd Jan 20207:00 amRNSChange of Auditor
10th Jan 20204:40 pmRNSSecond Price Monitoring Extn
10th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 202011:09 amRNSHolding(s) in Company
8th Jan 202010:47 amRNSHolding(s) in Company
31st Dec 20198:00 amRNSUpdate re the sale of Healthcare services business
23rd Dec 201912:03 pmRNSHolding(s) in Company
17th Dec 20192:22 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSUpdate re the sale of Healthcare services business
22nd Oct 20194:10 pmRNSHolding(s) in Company
22nd Oct 20194:10 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSettlement with Slater & Gordon (UK) 1 Limited
16th Oct 20194:37 pmRNSSettlement with Mr Robert Terry and others
17th Sep 20197:00 amRNSSale of Healthcare Services
4th Sep 20197:00 amRNSHalf-year Report
29th Aug 20197:03 amRNSCounterclaim against Slater & Gordon (UK) 1 Ltd
31st Jul 20197:00 amRNSAppointment of Nominated Adviser and Broker
5th Jul 20195:04 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSDirectorate Change
26th Jun 20192:14 pmRNSResult of AGM
13th Jun 20197:00 amRNSProposed counterclaim by Robert Terry and others
6th Jun 201910:23 amRNSHolding(s) in Company
3rd Jun 20197:00 amRNSAnnual Financial Report
9th May 20197:00 amRNSFinal Results
4th Apr 20191:32 pmRNSHolding(s) in Company
3rd Apr 201910:24 amRNSHolding(s) in Company
28th Mar 201910:25 amRNSHolding(s) in Company
12th Feb 20194:14 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSPre-close trading update
24th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20182:31 pmRNSHolding(s) in Company
6th Nov 20184:57 pmRNSHolding(s) in Company
11th Oct 20183:33 pmRNSHolding(s) in Company
9th Oct 20185:20 pmRNSHolding(s) in Company
25th Sep 20185:50 pmRNSHolding(s) in Company
13th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSHalf-year Report
23rd Aug 201810:39 amRNSHolding(s) in Company
2nd Aug 20182:20 pmRNSHolding(s) in Company
29th Jun 201810:35 amRNSHolding(s) in Company
27th Jun 201811:55 amRNSAGM Results
17th May 20187:34 amRNSAnnual Financial Report
1st May 201812:27 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSFinal Results
13th Apr 20184:21 pmRNSHolding(s) in Company
16th Mar 201810:40 amRNSHolding(s) in Company
20th Feb 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.